1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2016-2020 World HIV/AIDS Diagnostic Testing Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

                - Hospitals                - Public Health Labs             - Commercial/Private Labs
                - Blood Banks          - Physician Offices                - Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Table Of Contents

2016-2020 World HIV/AIDS Diagnostic Testing Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers'
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VI. Japan: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IX. USA: Market Size, Growth and Major Suppliers'
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests

France: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

France: HIV Ag Test Volume and Sales Forecasts
By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales

France: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Germany: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Germany: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Germany: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Italy: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales

Italy: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Japan: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Japan HIV Ag Test Volume and Sales Forecasts
By Market Segment
Japan: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Japan: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Japan: AIDS Diagnostics Market by Major Supplier
Japan: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

Spain: HIV Ag Test Volume and Sales Forecasts
By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

UK: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

UK: HIV Ag Test Volume and Sales Forecasts
By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

USA: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts
By Market Segment

USA: HIV Ag Test Volume and Sales Forecasts
By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales

USA: Western Blot/Other Confirmatory Tests Volume
and Sales Forecasts by Market Segment

USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

Contains 288 pages and 43 tables

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s AIDS Related Kaposi’s Sarcoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one ...


Download Unlimited Documents from Trusted Public Sources

Tuberculosis Statistics

  • February 2017
    200 pages
  • Infectious Dise...  

    Tuberculosis  

  • United States  

    North America  

    Europe  

View report >

Dementia Statistics and Infectious Disease Statistics

  • February 2017
    141 pages
  • Dementia  

    Infectious Dise...  

    Healthcare  

  • Asia  

View report >

HIV AIDS Statistics in South Africa

  • February 2017
    8 pages
  • HIV AIDS  

    Food  

  • South Africa  

View report >

Related Market Segments :

HIV AIDS

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.